SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424,814 | -51.5% | 59,681 | -30.6% | 0.00% | -50.0% |
| Q2 2023 | $876,216 | +155.6% | 86,000 | +127.5% | 0.00% | +100.0% |
| Q1 2023 | $342,841 | +1082.2% | 37,809 | +847.6% | 0.00% | – |
| Q4 2022 | $29,000 | -9.4% | 3,990 | -19.0% | 0.00% | – |
| Q3 2022 | $32,000 | +146.2% | 4,926 | +85.0% | 0.00% | – |
| Q2 2022 | $13,000 | -38.1% | 2,663 | -26.8% | 0.00% | – |
| Q1 2022 | $21,000 | +5.0% | 3,637 | -6.9% | 0.00% | – |
| Q4 2021 | $20,000 | -20.0% | 3,907 | +1.3% | 0.00% | – |
| Q3 2021 | $25,000 | +1150.0% | 3,857 | +980.4% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 357 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |